North Texas Health Experts Fear Too Many People Will Not Get COVID-19 Vaccine
Health officials estimate that between 60% and 80% of Americans would need to get a Covid-19 vaccine to create what's called a "herd immunity."
Watch CBS News
Health officials estimate that between 60% and 80% of Americans would need to get a Covid-19 vaccine to create what's called a "herd immunity."
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine.
As drugmakers seek federal approval, the Texas Nurses Association says they're training on how to deploy the COVID-19 vaccine and the equipment needed to store it.
Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine.
The Texas Department of State Health Services says more than 3,000 providers have signed up to receive and administer COVID vaccines.
"This is well above my expectations, I think I would have been happy if it made 60% effective rate, so to see 94.5%, that's very exciting. It's very good news," said Chief Boyd.
Moderna said Monday its shots provide strong protection and appears to be 94.5% effective, according to preliminary data from the company's still ongoing study.
The Texas Department of State Health Services is allocating an initial shipment of an emergency treatment for COVID-19 to be distributed to acute care hospitals as early as next week.
Tom Thumb and Albertsons pharmacies will receive a direct allocation of the COVID-19 vaccine once it is authorized or approved and recommended for use in the U.S.
Oil prices skyrocketed Monday after Pfizer revealed new coronavirus vaccine data that could offer hope to millions and clear some of the black clouds hovering over the energy industry.
Yet another COVID-19 vaccine trial has been paused. Johnson & Johnson put the brakes on their coronavirus vaccine study after a participant became ill.
Only Texas and 2 other states in the U.S. are reporting a decline in new coronavirus cases compared to last week, as the country hit its highest daily rate of new cases in nearly 60 days.
A COVID-19 vaccine could be available by November, but not for everyone, said CDC director Robert Redfield while testifying in front of a U.S. Senate subcommittee.
Find answers to some of your questions about the coronavirus — as the world continues to face it, fight it, and understand it.
According to the Congressional Research Service, the U.S. Supreme Court has ruled that states have the "authority to require mandatory vaccinations."
The first round of patients participating in Pfizer's COVID-19 vaccine study got their doses on Wednesday in North Texas.
The vaccine was developed by Moscow's Gamaleya Institute after less than two months of human testing, Reuters reports.
Next week, the first COVID-19 vaccine tested in the country is entering its final stage of testing.
